Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03030008 TxB1 cPLA2i 1.0 BCD110605C28 0.13 pmol/ml medium
LMFA03030008 TxB1 cPLA2i 1.0 BCD110605C30 0.121 pmol/ml medium
LMFA03030008 TxB1 cPLA2i 1.0 BCD110605C29 0.097 pmol/ml medium
LMFA03030008 TxB1 cPLA2i 20.0 BCD110605C64 0.083 pmol/ml medium
LMFA03030008 TxB1 cPLA2i 20.0 BCD110605C66 0.07 pmol/ml medium
LMFA03030008 TxB1 cPLA2i 20.0 BCD110605C65 0.058 pmol/ml medium
LMFA03030008 TxB1 PLDi 1.0 BCD110605C16 0.188 pmol/ml medium
LMFA03030008 TxB1 PLDi 1.0 BCD110605C17 0.182 pmol/ml medium
LMFA03030008 TxB1 PLDi 1.0 BCD110605C18 0.168 pmol/ml medium
LMFA03030008 TxB1 PLDi 20.0 BCD110605C54 0.068 pmol/ml medium
LMFA03030008 TxB1 PLDi 20.0 BCD110605C52 0.074 pmol/ml medium
LMFA03030008 TxB1 PLDi 20.0 BCD110605C53 0.084 pmol/ml medium
LMFA03030008 TxB1 KDO+cPLA2i 1.0 BCD110605C32 0.103 pmol/ml medium
LMFA03030008 TxB1 KDO+cPLA2i 1.0 BCD110605C31 0.106 pmol/ml medium
LMFA03030008 TxB1 KDO+cPLA2i 1.0 BCD110605C33 0.109 pmol/ml medium
LMFA03030008 TxB1 KDO+cPLA2i 20.0 BCD110605C68 0.055 pmol/ml medium
LMFA03030008 TxB1 KDO+cPLA2i 20.0 BCD110605C69 0.064 pmol/ml medium
LMFA03030008 TxB1 KDO+cPLA2i 20.0 BCD110605C67 0.06 pmol/ml medium
LMFA03030008 TxB1 KDO+PLDi 1.0 BCD110605C19 0.135 pmol/ml medium
LMFA03030008 TxB1 KDO+PLDi 1.0 BCD110605C20 0.152 pmol/ml medium
LMFA03030008 TxB1 KDO+PLDi 1.0 BCD110605C21 0.14 pmol/ml medium
LMFA03030008 TxB1 KDO+PLDi 20.0 BCD110605C56 0.072 pmol/ml medium
LMFA03030008 TxB1 KDO+PLDi 20.0 BCD110605C57 0.059 pmol/ml medium
LMFA03030008 TxB1 KDO+PLDi 20.0 BCD110605C55 0.056 pmol/ml medium
LMFA03030008 TxB1 KDO+ATP+cPLA2i 1.0 BCD110605C37 0.118 pmol/ml medium
LMFA03030008 TxB1 KDO+ATP+cPLA2i 1.0 BCD110605C38 0.18 pmol/ml medium
LMFA03030008 TxB1 KDO+ATP+cPLA2i 1.0 BCD110605C39 0.114 pmol/ml medium
LMFA03030008 TxB1 KDO+ATP+cPLA2i 20.0 BCD110605C74 0.104 pmol/ml medium
LMFA03030008 TxB1 KDO+ATP+cPLA2i 20.0 BCD110605C75 0.092 pmol/ml medium
LMFA03030008 TxB1 KDO+ATP+cPLA2i 20.0 BCD110605C73 0.118 pmol/ml medium
LMFA03030008 TxB1 KDO+ATP+PLDi 1.0 BCD110605C25 0.121 pmol/ml medium
LMFA03030008 TxB1 KDO+ATP+PLDi 1.0 BCD110605C27 0.111 pmol/ml medium
LMFA03030008 TxB1 KDO+ATP+PLDi 1.0 BCD110605C26 0.124 pmol/ml medium
LMFA03030008 TxB1 KDO+ATP+PLDi 20.0 BCD110605C61 0.093 pmol/ml medium
LMFA03030008 TxB1 KDO+ATP+PLDi 20.0 BCD110605C62 0.079 pmol/ml medium
LMFA03030008 TxB1 KDO+ATP+PLDi 20.0 BCD110605C63 0.15 pmol/ml medium
LMFA03030008 TxB1 KDO + ATP 1.0 BCD110605C15 0.177 pmol/ml medium
LMFA03030008 TxB1 KDO + ATP 1.0 BCD110605C14 0.249 pmol/ml medium
LMFA03030008 TxB1 KDO + ATP 1.0 BCD110605C13 0.21 pmol/ml medium
LMFA03030008 TxB1 KDO + ATP 20.0 BCD110605C49 0.084 pmol/ml medium
LMFA03030008 TxB1 KDO + ATP 20.0 BCD110605C50 0.081 pmol/ml medium
LMFA03030008 TxB1 KDO + ATP 20.0 BCD110605C51 0.069 pmol/ml medium
LMFA03030008 TxB1 KDO 1.0 BCD110605C08 0.271 pmol/ml medium
LMFA03030008 TxB1 KDO 1.0 BCD110605C07 0.279 pmol/ml medium
LMFA03030008 TxB1 KDO 1.0 BCD110605C09 0.247 pmol/ml medium
LMFA03030008 TxB1 KDO 20.0 BCD110605C45 0.095 pmol/ml medium
LMFA03030008 TxB1 KDO 20.0 BCD110605C44 0.093 pmol/ml medium
LMFA03030008 TxB1 KDO 20.0 BCD110605C43 0.088 pmol/ml medium
LMFA03030008 TxB1 C 0.0 BCD110605C03 0.554 pmol/ml medium
LMFA03030008 TxB1 C 0.0 BCD110605C01 0.653 pmol/ml medium